Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive genomic profiling of a unique liposarcoma arising in a patient with Li-Fraumeni syndrome and the novel detection of c-myc amplification: a case report. | Diagn Pathol | 2022 | 36514176 | PubTator, text mining | PubMed |
| The role of tumor microenvironment reprogramming in primary liver cancer chemotherapy resistance. | Front Oncol | 2022 | 36505831 | PubTator, text mining | PubMed |
| Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors. | Front Chem | 2022 | 36465863 | PubTator, text mining | PubMed |
| A pyroptosis expression pattern score predicts prognosis and immune microenvironment of lung squamous cell carcinoma. | Front Genet | 2022 | 36437960 | PubTator, text mining | PubMed |
| Targeted Therapies for Hepatocellular Carcinoma Treatment: A New Era Ahead-A Systematic Review. | Int J Mol Sci | 2022 | 36430594 | PubTator, text mining | PubMed |
| ProxyBind: A compendium of binding sites for proximity-induced pharmacology. | Comput Struct Biotechnol J | 2022 | 36420167 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Pleural plasmacytomas in a patient with multiple myeloma relapse. | Respir Med Case Rep | 2022 | 36411823 | PubTator, text mining | PubMed |
| PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum. | Nat Microbiol | 2022 | 36396942 | PubTator, text mining | PubMed |
| Adaptation of African swine fever virus to porcine kidney cells stably expressing CD163 and Siglec1. | Front Immunol | 2022 | 36389805 | PubTator, text mining | PubMed |
| Breast cancer liver metastasis: Pathogenesis and clinical implications. | Front Oncol | 2022 | 36387238 | PubTator, text mining | PubMed |
| Collective genomic segments with differential pleiotropic patterns between cognitive dimensions and psychopathology. | Nat Commun | 2022 | 36369282 | PubTator, text mining | PubMed |
| Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma. | J Clin Med | 2022 | 36362802 | PubTator, text mining | PubMed |
| The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells. | Int J Mol Sci | 2022 | 36361992 | PubTator, text mining | PubMed |
| The Promoter Region of the Proto-Oncogene MST1R Contains the Main Features of G-Quadruplexes Formation. | Int J Mol Sci | 2022 | 36361696 | PubTator, text mining | PubMed |
| hnRNP A1 in RNA metabolism regulation and as a potential therapeutic target. | Front Pharmacol | 2022 | 36339596 | PubTator, text mining | PubMed |
| Meeting an un-MET need: Targeting MET in non-small cell lung cancer. | Front Oncol | 2022 | 36338701 | PubTator, text mining | PubMed |
| The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors. | Explor Target Antitumor Ther | 2022 | 36338516 | PubTator, text mining | PubMed |
| STEAP2 promotes osteosarcoma progression by inducing epithelial-mesenchymal transition via the PI3K/AKT/mTOR signaling pathway and is regulated by EFEMP2. | Cancer Biol Ther | 2022 | 36316642 | PubTator, text mining | PubMed |
| The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor. | Int J Mol Sci | 2022 | 36293286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=12